Search for: "Pharmaceutical Associates, Inc." Results 221 - 240 of 1,891
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Nov 2018, 12:10 pm by Schachtman
Asserting that statistical significance is misleading because it never describes the size of an association, which the Rothman brief does, is like telling us that color terms tell us nothing about the mass of a body. [read post]
19 Aug 2010, 10:41 am by Bob Kraft
Wall Street Journal reports that the FDA revealed safety concerns about Jazz Pharmaceuticals Inc. [read post]
28 Oct 2010, 8:15 am by Thomas Anapol
Both the GastroMARK and the Feraheme websites failed to identify risks associated with the drugs. [read post]
6 Oct 2009, 12:13 pm
As a follow-up to last week's post about GlaxoSmithKline's new CME standards, it appears that some pharmaceuticals companies are not so keen on self-regulation. [read post]
24 Jan 2007, 2:18 pm
Plaintiff Alleges Taking Prempro For Almost Ten Years Caused Her Breast Cancer (Posted by Tom Lamb at DrugInjuryWatch.com) In the third hormone replacement therapy (HRT) case to get to trial, 71-year old Helene Rush alleges that her breast cancer diagnosed in 1999 is due to the fact that she took Prempro, Wyeth Pharmaceuticals Inc.'s estrogen-progestin hormone therapy medication, for nearly ten years. [read post]
12 Jun 2013, 9:09 am by Legal Reader
  Currently, the most popular IUD in the United States is Mirena®, a product manufactured by Bayer Pharmaceuticals, Inc. that is associated with a high rate of IUD migration and uterine perforation. [read post]
12 Jun 2013, 9:09 am by Legal Reader
  Currently, the most popular IUD in the United States is Mirena®, a product manufactured by Bayer Pharmaceuticals, Inc. that is associated with a high rate of IUD migration and uterine perforation. [read post]
24 Mar 2014, 10:45 am by Dr. Shezad Malik
A 58-year-old California man who suffered injuries after using the testosterone therapy Testim has sued manufacturer Auxilium Pharmaceuticals Inc., claiming it coordinated a massive ad campaign to aggressively promote the need for its product while failing to warn users of life-threatening side effects. [read post]
7 Mar 2012, 9:15 am by Andrew Ramonas
The firm in 2011 advocated for health care industry members that included the Blue Cross and Blue Shield Association and pharmaceutical and medical device company Hospira Inc., according to congressional records. [read post]
8 Sep 2009, 4:00 am
As written by the Associated Press, the huge fine levied last week against Pfizer is unlikely to stop pharmaceutical companies from the profitable practice of off-label marketing of prescription drugs. [read post]
9 Jul 2018, 6:30 pm by Todd Presnell
Boehringer Ingelheim Pharmaceuticals, Inc., 2018 WL 3028972 (CADC June 19, 2018). [read post]
9 Jul 2018, 6:30 pm by Todd Presnell
Boehringer Ingelheim Pharmaceuticals, Inc., 2018 WL 3028972 (CADC June 19, 2018). [read post]
6 Mar 2018, 2:10 pm by Tom Lamb
We are doing this review because it was during April 2013 that Novartis Pharmaceuticals Canada Inc. took these actions: Sent a so-called "Dear Doctor" letter in Canada (but not the US) warning about some serious side effects associated with Tasigna; and, Issued a Tasigna drug label change in Canada (but not the US) with new information concerning those Tasigna side effects. [read post]
22 Oct 2009, 7:00 am
By over-promising and minimizing the risks associated with a drug, a manufacturer puts thousands of innocent consumers in danger of suffering as a result. [read post]
27 Feb 2018, 9:12 am by Tom Lamb
Relevant parts of this April 9, 2013 letter from Novartis Pharmaceuticals Canada Inc. are set forth below: Dear Healthcare Professional: Subject: Updated information regarding the possible risk of developing atherosclerosis-related diseases with the use of TASIGNA* (nilotinib) Novartis Pharmaceuticals Canada Inc. [read post]
22 Aug 2016, 1:05 pm by jromDLT
You may be entitled to compensation for your medical bills, lost wages, pain and suffering and other damages that can be pursued in a defective drug lawsuit against the manufacturer of Pradaxa, Boehringer Ingelheim Pharmaceuticals, Inc. [read post]